The Aperlena Verdict
Open raceNo supplier dominates: 32 different companies have won the last 33 comparable contracts from this buyer over 5 years. This is a genuinely open race.
Based on 33 comparable awards by this buyer in this sector over 5 years. Every verdict is recorded before the outcome and graded against the award notice. How we score ourselves.
Summary
Machine-generated summaryA Polish public procurement for the delivery of medicinal products, divided into 31 parts. Parts 1 to 30 cover drug programmes, each dedicated to a specific active substance, including tafasitamab, avatrombopag, ibrutinib, daratumumab, acalabrutinib, ribociclib, alpelisib, darolutamide, gilteritinib, sotorasib, tucatinib, trastuzumab deruxtecan, isatuximab, zanubrutinib, esketamine, dostarlimab, capivasertib, fruquintinib, tremelimumab, tislelizumab, amivantamab, lorlatinib, serplulimab, binimetinib, encorafenib, mosunetuzumab, glofitamab and cabozantinib. Part 30 covers immunoglobulins, and Part 31 covers immunoglobulins for secondary immunodeficiencies. The products are anticancer, immunomodulating and anti-infective medicines for systemic use.
Description
31 lots
- Lot 1
- Część nr 1: Tafasitamab estimated €10,430 · 12 months
- Lot 2
- Część nr 2: Awatrombopag estimated €5,991 · 12 months
- Lot 3
- Część nr 3: Ibrutynib estimated €239,023 · 12 months
- Lot 4
- Część nr 4: Daratumumab estimated €1,287,451 · 12 months
- Lot 5
- Część nr 5: Awaprytynib estimated €100,965 · 12 months
- Lot 6
- Część nr 6: Rybocyklib estimated €215,625 · 13 months
- Lot 7
- Część nr 7: Alpelisyb estimated €15,419 · 12 months
- Lot 8
- Część nr 8: Darolutamid estimated €35,390 · 13 months
- How tenders are scored
- cena: 100 percent
Show 23 more lots
- Lot 9
- Część nr 9: Gilterytynib estimated €193,273 · 12 months
- Lot 10
- Część nr 10: Sotorasib estimated €24,731 · 12 months
- Lot 11
- Część nr 11: Tukatynib estimated €31,388 · 12 months
- Lot 12
- Część nr 12: Trastuzumab derukstekan estimated €30,865 · 12 months
- Lot 13
- Część nr 13: Izatuksymab estimated €23,449 · 12 months
- Lot 14
- Część nr 14: Zanubrutynib estimated €1,541,765 · 12 months
- Lot 15
- Część nr 15: Esketamina estimated €5,272 · 12 months
- Lot 16
- Część nr 16: Dostarlimab estimated €263,054 · 13 months
- Lot 17
- Część nr 17: Kaplacyzumab estimated €48,691 · 12 months
- Lot 18
- Część nr 18: Fruquintinibum estimated €56,024 · 12 months
- Lot 19
- Część nr 19: Tremelimumabum estimated €11,383 · 12 months
- Lot 20
- Część nr 20: Tislelizumabum estimated €47,880 · 12 months
- Lot 21
- Część nr 21: Amiwantamab estimated €61,493 · 12 months
- Lot 22
- Część nr 22: Lazertynib estimated €67,275 · 12 months
- Lot 23
- Część nr 23: Serplulimab estimated €48,889 · 12 months
- Lot 24
- Część nr 24: Binimetynib estimated €30,425 · 12 months
- Lot 25
- Część nr 25: Enkorafenib estimated €22,330 · 12 months
- Lot 26
- Część nr 26: Kapiwasertyb estimated €25,136 · 12 months
- Lot 27
- Część nr 27: Mosunetuzumab estimated €66,125 · 12 months
- Lot 28
- Część nr 28: Glofitamab estimated €28,832 · 12 months
- Lot 29
- Część nr 29: Cabozantinibum estimated €62,245 · 12 months
- Lot 30
- Część nr 30: Immunoglobuliny estimated €276,829 · 12 months
- Lot 31
- Część nr 31: Immunoglobuliny estimated €447,131 · 12 months
As the official notice states them.
Bid or no-bid?
Six questions before you commit a team. Under each one, what the register holds on it. The answers are yours.
Can I bid?
- Open procedure: any interested supplier may submit a bid. Above the EU threshold: open to companies from any EU country.
- The notice is written in Polish.
- Certificates from another EU country? Check the equivalents on eCertis
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Report an error in this notice
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 2 days ago
Expected award price
- likely award for this notice, from its published estimate of €5,346,977
- €5.8M to €6.6M
This buyer's comparable awards in this sector came in at a median of 111% of their published estimate, half of them between 109% and 123%, based on 11 awards of the last 3 years.
Each award is compared with the estimate of the same lots, framework agreements excluded. A published estimate may include options and renewals, so an award under it is not always a discount.
What this buyer has paid before
Based on 74 comparable contracts this buyer awarded in this sector over the last 4 years.
- This notice
- €5.3M
- Median award
- €962,984
- Middle half of past awards
- €337,547 to €2.1M
The estimate is larger than three in four past awards.
Most recent awards
- Ogólne środki przeciwinfekcyjne do użytku ogólnoustrojowego, szczepionki, środki przeciwnowotworowe oraz immunomodulacyjne - Dostawy produktów leczniczych €298,885
- Ogólne środki przeciwinfekcyjne do użytku ogólnoustrojowego, szczepionki, środki przeciwnowotworowe oraz immunomodulacyjne - Dostawy produktów leczniczych €1,512,378
- Meble medyczne - Dostawa wyposażenia meblowego dla Szpitala Specjalistycznym im. J. Śniadeckiego w Nowym Sączu. €158,947
- Meble medyczne - Dostawa wyposażenia meblowego dla Szpitala Specjalistycznym im. J. Śniadeckiego w Nowym Sączu. €161,220
- Urządzenia medyczne - Dostawa sprzętu i aparatury dla Pawilonu Laboratoryjnego - Aptecznego Szpitala Specjalistycznego im. J. Śniadeckiego w Nowym Sączu. €3,526
Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.
The buyer
Full buyer profileSzpital Specjalistyczny im. Jędrzeja Śniadeckiego
- notices in the register
- 164
- awards
- 105
- awarded in total
- €985.3M
Who wins its contracts
Many suppliers- different companies won its awards
- 42
- of the awards went to the three most frequent winners
- 11%
- of its calls state an estimated value
- 89%
Based on 44 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.
Competition
- tenders per lot on average (open and restricted procedures)
- 2.2
- of those lots received a single tender
- 53%
- of the awards went to companies based in another country
- 2%
As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.
One dot per award, on the day it was signed, sized by its value. A ring is an award with no published value.
Who usually wins this buyer's contracts in this sector
Based on 33 awards with a linked company profile over the last 5 years.
5 open tenders right now
- Medical materials - Supply of single-use medical equipment 3 days left
- General systemic anti-infective medicines, vaccines, anticancer and immunomodulating agents - Supply of medicinal products 9 days left
- General anti-infectives for systemic use, vaccines, antineoplastic and immunomodulating agents - Supply of medicinal products 14 days left
Market context
Larger than 88% of the open notices in Medical equipment & pharmaceuticals across Europe.
- open now in Medical equipment & pharmaceuticals
- 8,119
- median open notice
- €311,053
Who wins in this market
Many suppliersPoland · Medical equipment & pharmaceuticals
- different companies won awards here
- 13,424
- of the awards went to the three most frequent winners
- 4%
- buyers awarded contracts here
- 1,462
Based on 23,003 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.
Competition
- tenders per lot on average (open and restricted procedures)
- 1.8
- of those lots received a single tender
- 63%
- of the awards went to companies based in another country
- 2%
- of the tenders came from another country
- 2%
As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.
Similar tenders
Open now
Awarded before
Never miss a tender like this
995 new notices in Medical equipment & pharmaceuticals in Poland in the last 7 days. Get an email when new ones appear. Free.
Set up my alertOr follow just its CPV code, General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents: an email when new tenders arrive under it, no account needed.